Neuropeptide Y1 and Y5 Receptor Antagonists as Potential Anti-Obesity Drugs: Current Status

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 11, 2014-10 ,pp. : 896-919

Bentham Science Publishers

Access to resources Recommend Favorite

NPY Y2 and Y4 Receptors Selective Ligands: Promising Anti-Obesity Drugs?

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 17, 2007-09 ,pp. : 1734-1742

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptide Y (NPY) Family of Hormones: Progress in the Development of Receptor Selective Agonists and Antagonists

By  

Current Pharmaceutical Design, Vol. 9, Iss. 15, 2003-06 ,pp. : 1165-1175

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptide Y receptor antagonists in obesity

By Gehlert D.R.   Hipskind P.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1827-1838

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological characterization of human NPFF 1 and NPFF 2 receptors expressed in CHO cells by using NPY Y 1 receptor antagonists

By Mollereau C.   Mazarguil H.   Marcus D.   Quelven I.   Kotani M.   Lannoy V.   Dumont Y.   Quirion R.   Detheux M.   Parmentier M.   Zajac J.-M.  

European Journal of Pharmacology, Vol. 451, Iss. 3, 2002-09 ,pp. : 245-256

Elsevier

Access to resources Recommend Favorite